Ajax-Loading

Johnson & Johnson - Operating Expenses

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Operating-Expenses" stands at 38.69 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.

Johnson & Johnson's third quarter result of 9.59 Billion USD for the item "Operating Expenses" represents an increase of 3.11 percent compared to it's second quarter result.

Also, Johnson & Johnson's third quarter result of 9.59 Billion USD for the item "Operating Expenses" represents a decrease of -6.22 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 38.69 Billion USD for the item "Operating Expenses" represents a decrease of -1.62 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 2.51 percent compared to the value the year prior.
The 1 year change in percent is 2.51.
The 3 year change in percent is -7.61.
The 5 year change in percent is 17.86.
The 10 year change in percent is 29.17.

The Serie's long term average value is 33.43 Billion United States Dollars. It's latest available value, on 09/30/2025, is 15.73 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2012, to it's latest available value, on 09/30/2025, is +38.08%.
The Serie's change in percent from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is -7.61%.

Operating Expenses for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Operating Expenses905,699,262,464.00
LogoAbbVie Inc - Operating Expenses399,570,305,024.00
LogoRoche Holding AG - Operating Expenses317,433,206,677.55
LogoAstraZeneca PLC - Operating Expenses280,205,508,085.11
LogoNovartis AG - Operating Expenses255,096,620,580.91